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background.
 
CO
 
2
 
 laser surgery is a treatment modality for cu-
taneous neurofibromas.
 
objective.
 
Hypertrophic and atrophic scars can result from treat-
 
ment with CO
 
2
 
 laser surgery. We present a case of cutaneous neu-
rofibromatosis that developed hypertrophic scars postoperatively.
 
methods.
 
Continuous wave CO
 
2
 
 laser surgery therapy was ap-
plied to the patient.
 
results.
 
Hypertrophic scars developed 2 months after therapy.
 
conclusion. 
 
With a preliminary test treatment the patient is
able to see the expected result.
 
VON RECKLINGHAUSEN neurofibromatosis, also
known as neurofibromatosis 1 (McK 162200), is a
disease with skin tumors derived from peripheral
nerves. Von Recklinghausen neurofibromatosis is an
inherited neuroectodermal abnormality characterized
by the presence of multiple neurofibromas, six or
more café au lait macules (larger than 15 mm postpu-
berty), axillary freckles, hypertrophic and cystic bone
lesions, and Lisch nodules in the iris. The mode of in-
heritance is autosomal dominant on gene 17q11.2.
This gene is responsible for the production of the tu-
mor suppressor neurofibromin. With a prevalence of 1
in 2500 births, it is one of the most prevalent genetic
defects.
 
1
 
Because of the psychological impact of the disease,
treatment to remove the neurofibromas which stigma-
tize the patient is often requested.
 
2,3
 
 CO
 
2
 
 laser vapor-
ization is a simple procedure that quickly removes the
tumor with minimal postoperative discomfort and ac-
ceptable cosmetic results.
 
3,4
 
Case Report
 
A 54-year-old woman with neurofibromatosis 1 pre-
sented with multiple café au lait macules and many fi-
bromas. Some of the other clinical symptoms of Von
Recklinghausen neurofibromatosis were also present:
axillary freckles and Lisch nodules in the iris. She had
no health problems or neurologic abnormalities at
that moment. Several excisions of fibromas had al-
ready been performed under local anesthesia. This
time she was seen in our department for CO
 
2
 
 treat-
ment of newly developed neurofibromas.
The neurofibromas were treated with continuous
wave CO
 
2
 
 laser, 20 W on defocused mode for the
sessile form and 10 W when excising the penduncu-
lated form. Under general anesthesia about 100 le-
sions were treated on face, arms, neck, and collar. Af-
ter the laser therapy, chlorohexidine 1% creme was
applied to the skin and instructions were given to
avoid sunlight.
The wounds healed by second intention in 3 weeks
time. Two months later the face, neck, and collar had
recovered well. However, several hypertrophic and
atrophic scars persisted on the arm, mostly on the
hand (Figure 1).
A 3 mm biopsy was performed on the left hand.
Histopathology showed an epidermis of normal thick-
ness. In the dermis, scar tissue formation was visible,
characterized by parallel lying fibroblasts and col-
lagen. In the depth, a remainder of the neurofibroma
was still present.
The patient was treated with 13-
 
cis
 
-retinoid 80 mg/
day. After 4 months of therapy an improvement of the
scars occurred. There was almost no erythema left and
the scars where flattened. Smooth depigmented scars
remained.
 
Discussion
 
The classic pattern of anatomic distribution of neu-
rofibromas is predominance on the trunk, as well as
head and neck involvement, with decreasing incidence
of lesions as one proceeds peripherally. The involve-
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ment of the hand, especially the palm, is quite uncom-
mon. Traditional surgical procedures are as variable
as the modes of presentation of the disease. Most com-
monly, repeated excisions of tumor involving the or-
bit, eyelids, cheeks, ears, lips, nose, and mouth are per-
formed, followed by appropriate reconstruction such
as skin graft, rhytidectomy, blepharoplasty, tarsorr-
haphy, or fascia sling. Frequently a secondary recon-
struction is necessary.
 
5
 
Very small fibromas cannot be treated by conven-
tional surgery, as they usually present in large num-
bers: the enormous amount of time required makes it
impossible to treat all the tumors. By contrast, laser
can perform this task quickly and without bleeding,
since the coagulating capability of the laser light beam
seals blood vessels up to about 0.5 mm in size immedi-
ately. For this reason CO
 
2
 
 laser has been developed
during the last 10–15 years and has become a stan-
dard treatment for neurofibromas of the skin.
 
2
 
 Its ad-
vantages include high patient satisfaction with rapid,
staged removal of thousands of neurofibromas, mini-
mal morbidity, and enhanced appearance. Healing is
complete in 6 weeks or less.
 
4
 
Our patient was in good health and had not re-
ported any previous abnormal scarring or keloid for-
mation even after earlier excisions. In port-wine stains,
hypertrophic scars are described after treatment with
CO
 
2
 
 laser, argon laser, and even with flashlamp-
pumped pulsed dye laser surgery, although treatment
is effective in most instances.
 
6–8
 
Hypertrophic scar formation occurring during the
first 3–4 months after CO
 
2
 
 laser therapy of neurofibro-
mas has been mentioned in the literature.
 
2
 
 It remains
an uncommon complication after CO
 
2
 
 laser therapy. In
neurofibromas, depigmented, flat, circular, and de-
pressed scars are seen.
 
2,4
 
 Instead of a complication of
treatment, CO
 
2
 
 laser therapy is frequently suggested as
an effective treatment for hypertrophic scars.
 
9
 
Suggested causes for scar formation after treatment
are localized infection, trauma within 24 hours, over-
lap of adjacent test pulses, the location, and higher
pulse level.
 
6,7,10
 
 In our case the scars were only present
on the underarm and hand. Thermal trauma could be
an explanation.
 
11
 
 Another explanation could be the
characteristics of the neurofibroma itself. Neurofibro-
mas are complex mixtures of Schwann cells, fibro-
blasts, perineural cells, vascular endothelium, and mast
cells.
 
12
 
 Interactions of these cells during trauma and
wound healing might produce scars. In our patient the
anatomic site, in combination with the wound depth,
was probably the cause of hypertrophic scarring, as
she had no problems on the face, neck, and collar after
the same treatment. Extremities take significantly longer
to heal as compared to the face and there is a greater
risk of hypertrophic scar formation.
 
13
 
Isotretinoin, a synthetic isomer of tretinoin (vitamin
A acid), has an anti inflammatory and antineoplastic
activity. Tretinoin can induce hypertrophic scar for-
mation. Nonetheless, it seems to work in many cases,
an apparent contradiction. In the literature there are
indications that retinoids can produce a reduction of
fibroblast proliferation and collagen synthesis. Also,
topical vitamin A has been shown to be effective in the
treatment of hypertrophic scars.
 
10,14
 
 Although there is
no evidence, we believe that treatment with 13-
 
cis
 
-ret-
inoid might reduce or inhibit further fibroblast prolif-
eration. Our patient responded to the treatment, but it
is doubtful whether the effect is due to the drug or to
spontaneous resolution of the hypertrophic scar.
The cosmetic disfigurement is the most important
issue in the decision to treat cutaneous symptoms of
neurofibromatosis. Treating patients with extensive
neurofibromas with CO
 
2
 
 laser is still the best choice.
However, it is strongly advised that a test treatment
be performed to judge the effectiveness of the proce-
dure and whether the developed scar is an acceptable
trade-off.
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